NCCN Prostate Cancer Very Low Risk Group
specificA prostate cancer risk group characterized by: clinical stage T1c, biopsy Gleason score of 6 or less, and PSA level less than 10.
Top Centers for NCCN Prostate Cancer Very Low Risk Group
Ranked by research excellence score (trials · grants · publications). Methodology →
No centers currently specializing in this cancer type.
Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →